EA
ORGO icon

Emerald Advisers’s Organogenesis Holdings ORGO Stock Holding History

Emerald Advisers’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-900
Closed -$15K – 271
2021
Q2 		$15K Buy
+900
New +$16.8K ﹤0.01% 281
2021
Q1 		– Sell
-3,500
Closed -$26K – 283
2020
Q4 		$26K Buy
+3,500
New +$16.6K ﹤0.01% 274

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
NMIMC
Northwestern Mutual Investment Management Company Milwaukee, Wisconsin $6.6B AUM 19.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Emerald Advisers's ORGO Position: Q3 2021 in Review

Emerald Advisers sold out of Organogenesis Holdings (ORGO) in Q3 2021, closing a stake of 900 shares — an estimated $15K sold.

Emerald Advisers first reported a position in ORGO in Q4 2020 and held it in 2 quarters. The position peaked at $26K in Q4 2020. 153 funds tracked by Wall St. Rank hold ORGO as of Q3 2021.

  • Emerald Advisers reported no remaining Organogenesis Holdings position as of Q3 2021 after selling out during the quarter.
  • Emerald Advisers sold 900 Organogenesis Holdings shares in Q3 2021, an estimated $15K.
  • Emerald Advisers first reported a position in Organogenesis Holdings in Q4 2020 and held it in 2 quarters.
  • Emerald Advisers's Organogenesis Holdings position peaked at $26K in Q4 2020.
  • 153 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2021.

Based on Emerald Advisers's 13F filing for Q3 2021, filed 28 Oct 2021.